Clinical Laserthermia Systems AB Promotes Michael Magnani to President of its U.S Subsidiary, CLS Americas Inc.
Clinical Laserthermia Systems AB (publ) (CLS AB), developer of high precision, image-guided focal laser ablation (FLA) systems, today announced it has promoted Mr. Michael Magnani to president of its U.S subsidiary Clinical Laserthermia Systems Americas Inc. (CLS Americas). Mr. Magnani previously served two years as the managing director and is succeeding Mr. Dan J. Mogren, who will be joining CLS Americas’ board of directors.CLS Americas is focused on supporting postmarket studies and managing the commercialization of the TRANBERG® | Thermal Therapy Systems as image-guided precision tools